S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

4basebio (4BB) Competitors

GBX 1,069
+34.00 (+3.29%)
(As of 03:44 PM ET)

4BB vs. FUM, SCLP, FARN, ETX, AVCT, POLB, HVO, TRX, AREC, and OXB

Should you be buying 4basebio stock or one of its competitors? The main competitors of 4basebio include Futura Medical (FUM), Scancell (SCLP), Faron Pharmaceuticals Oy (FARN), e-therapeutics (ETX), Avacta Group (AVCT), Poolbeg Pharma (POLB), hVIVO (HVO), Tissue Regenix Group (TRX), Arecor Therapeutics (AREC), and Oxford Biomedica (OXB). These companies are all part of the "biotechnology" industry.

4basebio vs.

4basebio (LON:4BB) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

4basebio has a net margin of 0.00% compared to Futura Medical's net margin of -299.73%. Futura Medical's return on equity of -66.35% beat 4basebio's return on equity.

Company Net Margins Return on Equity Return on Assets
4basebioN/A -97.29% -35.08%
Futura Medical -299.73%-66.35%-39.40%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
4basebio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Futura Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Futura Medical has higher revenue and earnings than 4basebio. 4basebio is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4basebio£311K440.32-£6.28M-£0.51-2,096.08
Futura Medical£1.70M62.93-£5.11M-£0.02-1,774.40

Futura Medical received 186 more outperform votes than 4basebio when rated by MarketBeat users.

CompanyUnderperformOutperform
4basebioN/AN/A
Futura MedicalOutperform Votes
186
64.36%
Underperform Votes
103
35.64%

In the previous week, Futura Medical had 1 more articles in the media than 4basebio. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for 4basebio. 4basebio's average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.

Company Overall Sentiment
4basebio Neutral
Futura Medical Neutral

9.1% of 4basebio shares are held by institutional investors. Comparatively, 36.0% of Futura Medical shares are held by institutional investors. 62.2% of 4basebio shares are held by insiders. Comparatively, 32.9% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

4basebio has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.

Summary

Futura Medical beats 4basebio on 9 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding 4BB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

4BB vs. The Competition

Metric4basebioBiotechnology IndustryMedical SectorLON Exchange
Market Cap£136.94M£170.95M£4.79B£1.40B
Dividend YieldN/A3.48%2.93%12.13%
P/E Ratio-2,096.08213.90227.141,769.98
Price / Sales440.3212,804.282,475.69323,373.90
Price / Cash16.0811.2047.0033.56
Price / Book38.185.104.552.53
Net Income-£6.28M-£18.84M£103.79M£182.13M
7 Day Performance4.80%-2.47%-4.42%-1.01%
1 Month Performance9.08%-4.97%-6.04%7.58%
1 Year Performance63.21%50.73%6.70%16.23%

4basebio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUM
Futura Medical
0 of 5 stars
GBX 37
-13.6%
N/A-26.3%£111.54M£1.70M-1,850.0012Negative News
High Trading Volume
SCLP
Scancell
0 of 5 stars
GBX 9.85
flat
N/A-47.4%£91.39M£5.27M-985.0051
FARN
Faron Pharmaceuticals Oy
0 of 5 stars
GBX 127.50
-3.8%
N/A-62.5%£87.73M£-725,000.00-303.5734
ETX
e-therapeutics
0 of 5 stars
GBX 12.50
flat
N/A-28.6%£73.04M£295,000.00-625.0034Gap Down
High Trading Volume
AVCT
Avacta Group
0 of 5 stars
GBX 54
+0.5%
N/A-62.8%£189.28M£16.02M-337.50120
POLB
Poolbeg Pharma
0 of 5 stars
GBX 9.80
-1.0%
N/A+35.1%£49MN/A-980.0012
HVO
hVIVO
0 of 5 stars
GBX 29
+0.7%
N/A+63.7%£197.31M£60.48M-1.00N/A
TRX
Tissue Regenix Group
0 of 5 stars
GBX 61.50
flat
N/A+10,323.7%£43.40M£29.49M-3,075.0082Positive News
AREC
Arecor Therapeutics
0 of 5 stars
GBX 140
-1.8%
N/A-52.4%£42.88M£3.38M-451.6151News Coverage
High Trading Volume
OXB
Oxford Biomedica
1.8287 of 5 stars
GBX 202.50
-0.2%
GBX 498.75
+146.3%
-52.8%£202.42M£119.02M-316.41891Gap Down

Related Companies and Tools

This page (LON:4BB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners